Welcome! You are visiting the MyeloRx web site.

Home
About Us
Contact Us
Site Map
Lead Compounds
Clinical Efficacy - Leuke
Natural Products
Our Strategy
Intellectual Property
Targets
Acute Myeloid Leukemia
Lead Compound - MRx102
MRx102
AML Xenograft Model (MV4-
Pilot Toxicity
Summary
MyeloRx LLC

 

Founded in 2007

 

Founder Contact
Neil R. Ackerman, Ph.D. – (Pfizer, Syntex, Cygnus)
neildoc1@gmail.com


Developing drugs for oncology and immunologic diseases based on natural products
Initial focus on acute myeloid leukemia (AML)

Additional interest in pancreatic cancer and immune-based diseases

 
MyeloRx LLC
(650) 759-3595
941 Railroad Avenue
Vallejo, CA 94692